Tata Chemicals Limited has informed the Exchange regarding a press release dated July 25, 2025, titled "Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended June 30, 2025".
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tata Chemicals reported Q1FY26 consolidated revenue from operations of ₹3,719 Cr, down 2% YoY due to the cessation of Lostock operations. Despite the revenue dip, consolidated EBITDA grew to ₹649 Cr from ₹574 Cr in Q1FY25, helped by lower costs. Profit After Tax (before NCI) jumped sharply to ₹316 Cr from ₹175 Cr a year earlier. On a standalone basis, revenue rose 12% to ₹1,169 Cr, EBITDA grew 15% to ₹270 Cr, and PAT from continuing operations was up 20% at ₹307 Cr. Net debt stood at ₹4,972 Cr (excluding lease liabilities of ₹760 Cr) as of June 30, 2025. Management flagged fluid global market conditions and tariff-related uncertainty, though said India and China demand remained stable.
Mixed signals for shareholders — consolidated revenue slipped YoY but profitability improved meaningfully on cost discipline, with nearly 80% PAT growth at the consolidated level. The standalone business showed strong double-digit growth across revenue, EBITDA, and profit, which is a positive read-through. Tariff uncertainties and pricing pressure remain near-term headwinds to watch.